Glenmark Recalls Blood Pressure Drug Ziac in US
Glenmark Pharmaceuticals recalls over 11,100 bottles of Ziac tablets in the US due to cross-contamination with a cholesterol drug. Check lot numbers and consult your doctor.
Category : Search result: AI in pharmaceuticals
Odisha Approves Pharma & Medtech Policy 2025
Odisha's new Pharma & Medtech Policy 2025 aims to make the state a strategic hub for healthcare manufacturing. The policy includes plans for dedicated industrial parks and a roadmap aligned with India's 2047 vision. Read more.
India Seeks Trade Expansion in Russia-Led Eurasian Bloc
India aims to boost exports to the Eurasian Economic Union, tackling non-tariff barriers in pharma and marine sectors. Talks progress ahead of President Putin's visit.
Cliniexperts Completes Akynzeo Phase IV Study for Glenmark
Cliniexperts successfully concludes Phase IV study of Glenmark's Akynzeo for CINV prevention. Breakthrough in cancer care with proven efficacy and safety results.
India, Slovenia Discuss Trade and Investment Promotion
India and Slovenia explored strengthening trade, investment, and sectoral cooperation in agriculture, pharma, energy, and more. Discover the key outcomes.
SMS Pharma Shares Jump 17% After USFDA Nod for Ranitidine
SMS Pharmaceuticals shares surged 17% after USFDA approved reformulated Ranitidine tablets. The approval marks the drug's return to US market after 5 years, boosting company's growth prospects.
India GCCs Focus on Innovation Over Scale in AI Era
India's Global Capability Centres are shifting from hiring numbers to innovation-driven outcomes. Pharma and fintech leaders reveal bold strategies prioritizing AI and blockchain over cost arbitrage.
Balaxi Pharma Soars 10% Despite 47% Yearly Loss
Balaxi Pharmaceuticals shares surged 10% to ₹39.5 in intraday trade Friday, defying market weakness. However, the stock remains down 47.42% YTD with retail investors facing significant wealth erosion.
Lincoln Pharma Aims for Rs 1000 Crore Revenue
Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.
Atorvastatin Recall: Cholesterol Drug Safety Alert
Critical drug recall affects millions of Indians taking Atorvastatin. Learn about the safety concerns, batch numbers, and what immediate steps you should take if you're on cholesterol medication.
Page 1 of 1